| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.586 | 0.004 | 0.586 | 5 Hydroxytryptamine agonist | 0.127 0.026 CID_154699508 | ||
| 0.532 | 0.017 | 0.532 | Calcium channel L-type activator | 0.452 0.05 CID_154699508 | ||
| 0.531 | 0.018 | 0.531 | GABA C receptor rho-3 antagonist | 0.324 0.1 CID_154699508 | ||
| 0.509 | 0.032 | 0.509 | Aldehyde oxidase inhibitor | |||
| 0.501 | 0.032 | 0.501 | 5 Hydroxytryptamine release inhibitor | 0.294 0.172 CID_154699508 | ||
| 0.451 | 0.011 | 0.451 | Calcium channel activator | 0.34 0.057 CID_154699508 | ||
| 0.404 | 0.02 | 0.404 | Peroxidase inhibitor | 0.186 0.063 CID_154699508 | ||
| 0.352 | 0.004 | 0.352 | Potassium channel (Ca-activated) activator | 0.177 0.02 CID_154699508 | ||
| 0.338 | 0.004 | 0.338 | Potassium channel large-conductance Ca-activated activator | 0.147 0.011 CID_154699508 | ||
| 0.339 | 0.01 | 0.339 | Interleukin 6 antagonist | 0.201 0.04 CID_154699508 | ||
| 0.352 | 0.025 | 0.352 | 5 Hydroxytryptamine uptake stimulant | 0.208 0.137 CID_154699508 | ||
| 0.369 | 0.057 | 0.369 | Cholesterol antagonist | 0.184 0.18 CID_154699508 | ||
| 0.311 | 0.005 | 0.311 | NMDA 2 receptor antagonist | 0.095 0.035 CID_154699508 | ||
| 0.313 | 0.009 | 0.313 | Cystathionine beta-synthase inhibitor | 0.161 0.036 CID_154699508 | ||
| 0.402 | 0.099 | 0.402 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.327 | 0.028 | 0.327 | Anesthetic general | |||
| 0.347 | 0.049 | 0.347 | Aryl hydrocarbon receptor agonist | 0.165 0.124 CID_154699508 | ||
| 0.317 | 0.029 | 0.317 | RNA-directed DNA polymerase inhibitor | 0.193 0.11 CID_154699508 | ||
| 0.309 | 0.024 | 0.309 | 5 Hydroxytryptamine 1E antagonist | 0.222 0.107 CID_154699508 | ||
| 0.267 | 0.004 | 0.267 | NMDA 2A receptor antagonist | 0.102 0.013 CID_154699508 | ||
| 0.266 | 0.004 | 0.266 | Acetylcholine release stimulant | 0.154 0.014 CID_154699508 | ||
| 0.261 | 0.005 | 0.261 | MAP kinase kinase 5 inhibitor | 0.203 0.03 CID_154699508 | ||
| 0.26 | 0.008 | 0.26 | Carbonic anhydrase VI inhibitor | 0.106 0.036 CID_154699508 | ||
| 0.259 | 0.009 | 0.259 | NMDA receptor antagonist | 0.104 0.044 CID_154699508 | ||
| 0.255 | 0.005 | 0.255 | HIV-1 integrase (Overall Integration) inhibitor | 0.149 0.025 CID_154699508 | ||
| 0.252 | 0.005 | 0.252 | Electrolyte absorption antagonist | 0.123 0.034 CID_154699508 | ||
| 0.256 | 0.012 | 0.256 | Carbonic anhydrase XV inhibitor | 0.106 0.059 CID_154699508 | ||
| 0.265 | 0.022 | 0.265 | Phospholipase C inhibitor | 0.157 0.092 CID_154699508 | ||
| 0.24 | 0.006 | 0.24 | 5 Hydroxytryptamine 3A agonist | 0.119 0.056 CID_154699508 | ||
| 0.234 | 0.005 | 0.234 | Toll-Like receptor 3 antagonist | 0.137 0.019 CID_154699508 | ||
| 0.257 | 0.028 | 0.257 | Nitric-oxide synthase stimulant | 0.195 0.098 CID_154699508 | ||
| 0.265 | 0.037 | 0.265 | Non-steroidal antiinflammatory agent | 0.175 0.091 CID_154699508 | ||
| 0.294 | 0.072 | 0.294 | 5 Hydroxytryptamine release stimulant | |||
| 0.328 | 0.11 | 0.328 | Histamine release inhibitor | |||
| 0.283 | 0.069 | 0.283 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.251 | 0.038 | 0.251 | Neurotrophic factor enhancer | |||
| 0.261 | 0.053 | 0.261 | Anticonvulsant | |||
| 0.27 | 0.065 | 0.27 | Interleukin agonist | |||
| 0.243 | 0.039 | 0.243 | MAP kinase kinase 3 inhibitor | 0.186 0.168 CID_154699508 | ||
| 0.218 | 0.019 | 0.218 | Ferrochelatase inhibitor | |||
| 0.219 | 0.02 | 0.219 | Catenin beta inhibitor | 0.145 0.119 CID_154699508 | ||
| 0.237 | 0.038 | 0.237 | Amyloid beta precursor protein antagonist | |||
| 0.273 | 0.077 | 0.273 | Insulysin inhibitor | |||
| 0.218 | 0.023 | 0.218 | MAP kinase kinase inhibitor | 0.134 0.062 CID_154699508 | ||
| 0.207 | 0.013 | 0.207 | DNA directed RNA polymerase inhibitor | 0.102 0.054 CID_154699508 | ||
| 0.221 | 0.027 | 0.221 | Anesthetic local | |||
| 0.212 | 0.018 | 0.212 | GABA C receptor agonist | 0.096 0.072 CID_154699508 | ||
| 0.256 | 0.063 | 0.256 | Tyrosine 3 hydroxylase inhibitor | 0.184 0.168 CID_154699508 | ||
| 0.33 | 0.138 | 0.33 | Cyclophilin D inhibitor | |||
| 0.31 | 0.125 | 0.31 | 15-Lipoxygenase inhibitor | |||
| 0.285 | 0.103 | 0.285 | Transcription factor NF kappa B inhibitor | |||
| 0.218 | 0.036 | 0.218 | Succinate dehydrogenase inhibitor | 0.156 0.102 CID_154699508 | ||
| 0.179 | 0.007 | 0.179 | Myeloperoxidase inhibitor | 0.095 0.042 CID_154699508 | ||
| 0.176 | 0.005 | 0.176 | NMDA receptor subunit 3B antagonist | 0.058 0.02 CID_154699508 | ||
| 0.187 | 0.016 | 0.187 | Interleukin 8 antagonist | |||
| 0.2 | 0.033 | 0.2 | Arachidonic acid antagonist | 0.137 0.104 CID_154699508 | ||
| 0.173 | 0.009 | 0.173 | MAP kinase kinase 1 inhibitor | 0.126 0.03 CID_154699508 | ||
| 0.284 | 0.125 | 0.284 | Calpain 2 inhibitor | |||
| 0.236 | 0.077 | 0.236 | DNA synthesis inhibitor | |||
| 0.188 | 0.03 | 0.188 | Glutamate receptor antagonist | |||
| 0.176 | 0.019 | 0.176 | GABA C receptor antagonist | 0.102 0.075 CID_154699508 | ||
| 0.196 | 0.041 | 0.196 | ATPase inhibitor | 0.139 0.121 CID_154699508 | ||
| 0.188 | 0.036 | 0.188 | GABA C receptor rho-2 antagonist | |||
| 0.159 | 0.009 | 0.159 | Lanosterol 14 alpha demethylase inhibitor | 0.096 0.061 CID_154699508 | ||
| 0.199 | 0.052 | 0.199 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.319 | 0.174 | 0.319 | Caspase 9 stimulant | |||
| 0.225 | 0.082 | 0.225 | Neuropeptide Y2 antagonist | |||
| 0.173 | 0.031 | 0.173 | Cyclooxygenase 3 inhibitor | 0.102 0.099 CID_154699508 | ||
| 0.177 | 0.037 | 0.177 | MAP kinase 3 inhibitor | 0.141 0.082 CID_154699508 | ||
| 0.144 | 0.007 | 0.144 | Alpha 2 adrenoreceptor agonist | |||
| 0.191 | 0.055 | 0.191 | Heat shock protein 90 alpha antagonist | 0.133 0.107 CID_154699508 | ||
| 0.182 | 0.047 | 0.182 | Hexokinase inhibitor | |||
| 0.199 | 0.064 | 0.199 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.145 | 0.011 | 0.145 | Glutamate release inhibitor | |||
| 0.161 | 0.027 | 0.161 | Heat shock protein 70 antagonist | |||
| 0.155 | 0.027 | 0.155 | DNA repair enzyme inhibitor | |||
| 0.149 | 0.022 | 0.149 | GABA C receptor rho-1 antagonist | |||
| 0.132 | 0.006 | 0.132 | NMDA receptor subunit 3A antagonist | 0.04 0.026 CID_154699508 | ||
| 0.247 | 0.121 | 0.247 | Interleukin 2 agonist | |||
| 0.222 | 0.096 | 0.222 | Superoxide dismutase inhibitor | |||
| 0.145 | 0.019 | 0.145 | NADH dehydrogenase inhibitor | 0.083 0.068 CID_154699508 | ||
| 0.204 | 0.079 | 0.204 | MAP kinase kinase 2 inhibitor | |||
| 0.209 | 0.084 | 0.209 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.162 | 0.038 | 0.162 | Cathepsin H inhibitor | |||
| 0.2 | 0.077 | 0.2 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.138 | 0.018 | 0.138 | Alpha adrenoreceptor agonist | |||
| 0.164 | 0.047 | 0.164 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.127 | 0.01 | 0.127 | Purinergic P2X1 antagonist | 0.065 0.037 CID_154699508 | ||
| 0.171 | 0.055 | 0.171 | Amylase inhibitor | |||
| 0.167 | 0.051 | 0.167 | Hemostatic | |||
| 0.171 | 0.055 | 0.171 | Heat shock protein 90 antagonist | |||
| 0.173 | 0.058 | 0.173 | Diuretic | |||
| 0.152 | 0.038 | 0.152 | Ca2+-transporting ATPase inhibitor | |||
| 0.124 | 0.012 | 0.124 | D-Ala-D-Ala ligase inhibitor | 0.091 0.042 CID_154699508 | ||
| 0.137 | 0.025 | 0.137 | Carbonic anhydrase XIII inhibitor | |||
| 0.137 | 0.024 | 0.137 | Triose-phosphate isomerase inhibitor | 0.101 0.046 CID_154699508 | ||
| 0.171 | 0.06 | 0.171 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.125 | 0.014 | 0.125 | GABA aminotransferase inhibitor | 0.081 0.045 CID_154699508 | ||
| 0.118 | 0.009 | 0.118 | NMDA receptor glycine site agonist | 0.081 0.028 CID_154699508 | ||
| 0.223 | 0.115 | 0.223 | Gastrin inhibitor | |||
| 0.127 | 0.019 | 0.127 | HIV-1 reverse transcriptase inhibitor | |||
| 0.133 | 0.026 | 0.133 | Potassium channel activator | |||
| 0.152 | 0.046 | 0.152 | Nav1.3 sodium channel blocker | |||
| 0.108 | 0.003 | 0.108 | Dihydrofolate reductase inhibitor | 0.061 0.009 CID_154699508 | ||
| 0.118 | 0.014 | 0.118 | NMDA receptor agonist | 0.069 0.037 CID_154699508 | ||
| 0.106 | 0.004 | 0.106 | 5 Hydroxytryptamine 2B agonist | 0.041 0.023 CID_154699508 | ||
| 0.111 | 0.011 | 0.111 | 5 Hydroxytryptamine 3 agonist | |||
| 0.171 | 0.076 | 0.171 | Tumour necrosis factor antagonist | |||
| 0.129 | 0.034 | 0.129 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.216 | 0.125 | 0.216 | Lipoxygenase inhibitor | |||
| 0.129 | 0.038 | 0.129 | MAP kinase 8 inhibitor | |||
| 0.127 | 0.038 | 0.127 | Urease inhibitor | 0.092 0.077 CID_154699508 | ||
| 0.135 | 0.047 | 0.135 | Alpha 2b adrenoreceptor antagonist | |||
| 0.108 | 0.02 | 0.108 | Aromatase inhibitor | |||
| 0.096 | 0.008 | 0.096 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.094 | 0.006 | 0.094 | Leukotriene A4 hydrolase inhibitor | |||
| 0.118 | 0.033 | 0.118 | Potassium channel (Voltage-sensitive) activator | |||
| 0.101 | 0.015 | 0.101 | NMDA 2C receptor antagonist | |||
| 0.152 | 0.067 | 0.152 | Protein kinase stimulant | |||
| 0.113 | 0.029 | 0.113 | Adrenaline agonist | |||
| 0.104 | 0.021 | 0.104 | T cell inhibitor | |||
| 0.149 | 0.066 | 0.149 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.086 | 0.003 | 0.086 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.059 0.008 CID_154699508 | ||
| 0.176 | 0.095 | 0.176 | Psychostimulant | |||
| 0.123 | 0.042 | 0.123 | DOPA decarboxylase inhibitor | |||
| 0.152 | 0.072 | 0.152 | CF transmembrane conductance regulator agonist | |||
| 0.098 | 0.018 | 0.098 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.096 | 0.016 | 0.096 | NMDA 2B receptor antagonist | |||
| 0.098 | 0.019 | 0.098 | Biliverdin reductase inhibitor | |||
| 0.111 | 0.032 | 0.111 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.082 | 0.004 | 0.082 | Alpha 1L adrenoreceptor agonist | 0.059 0.009 CID_154699508 | ||
| 0.146 | 0.069 | 0.146 | Adenylate cyclase stimulant | |||
| 0.15 | 0.074 | 0.15 | Phospholipase A2 inhibitor | |||
| 0.116 | 0.04 | 0.116 | Nitric-oxide synthase inhibitor | |||
| 0.125 | 0.051 | 0.125 | Falcipain 3 inhibitor | |||
| 0.139 | 0.065 | 0.139 | Nav1.2 sodium channel blocker | |||
| 0.14 | 0.067 | 0.14 | Nav1.6 sodium channel blocker | |||
| 0.079 | 0.006 | 0.079 | Immunoglobulin Fc receptor antagonist | 0.061 0.022 CID_154699508 | ||
| 0.089 | 0.015 | 0.089 | Heat shock protein 90 beta antagonist | |||
| 0.092 | 0.02 | 0.092 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.071 0.058 CID_154699508 | ||
| 0.103 | 0.03 | 0.103 | Phosphodiesterase 3A inhibitor | |||
| 0.116 | 0.044 | 0.116 | Creatine kinase inhibitor | |||
| 0.117 | 0.045 | 0.117 | UDP-glucose 4-epimerase inhibitor | |||
| 0.104 | 0.034 | 0.104 | Inducible nitric-oxide synthase inhibitor | |||
| 0.087 | 0.018 | 0.087 | Glutamate (mGluR6) antagonist | |||
| 0.083 | 0.015 | 0.083 | Carbonic anhydrase XIV inhibitor | |||
| 0.193 | 0.126 | 0.193 | Spasmolytic | |||
| 0.084 | 0.017 | 0.084 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.114 | 0.049 | 0.114 | Adenylate kinase inhibitor | |||
| 0.147 | 0.082 | 0.147 | Interferon gamma antagonist | |||
| 0.084 | 0.021 | 0.084 | Carbonic anhydrase VB inhibitor | |||
| 0.081 | 0.019 | 0.081 | MDM2 inhibitor | |||
| 0.068 | 0.009 | 0.068 | Dopamine beta hydroxylase inhibitor | |||
| 0.112 | 0.053 | 0.112 | Toll-Like receptor 4 antagonist | |||
| 0.118 | 0.059 | 0.118 | CDK3/cyclin E inhibitor | |||
| 0.102 | 0.044 | 0.102 | Histamine N-methyltransferase inhibitor | |||
| 0.207 | 0.149 | 0.207 | Nootropic | |||
| 0.067 | 0.009 | 0.067 | GABA B receptor antagonist | |||
| 0.073 | 0.015 | 0.073 | Topoisomerase II beta inhibitor | |||
| 0.141 | 0.084 | 0.141 | Acetylcholine M1 receptor antagonist | |||
| 0.092 | 0.036 | 0.092 | Cathepsin G inhibitor | |||
| 0.093 | 0.037 | 0.093 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.13 | 0.074 | 0.13 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.143 | 0.088 | 0.143 | Src kinase inhibitor | |||
| 0.059 | 0.005 | 0.059 | LFA antagonist | |||
| 0.079 | 0.025 | 0.079 | Dopamine uptake inhibitor | |||
| 0.084 | 0.031 | 0.084 | Secretase beta inhibitor | |||
| 0.075 | 0.022 | 0.075 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.072 | 0.019 | 0.072 | 5 Hydroxytryptamine 2 agonist | |||
| 0.085 | 0.033 | 0.085 | GABA B receptor agonist | |||
| 0.085 | 0.033 | 0.085 | Carbonic anhydrase V inhibitor | |||
| 0.136 | 0.084 | 0.136 | Pregnane X receptor agonist | |||
| 0.058 | 0.007 | 0.058 | Heme oxygenase inhibitor | 0.042 0.033 CID_154699508 | ||
| 0.109 | 0.057 | 0.109 | Nav1.1 sodium channel blocker | |||
| 0.08 | 0.029 | 0.08 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.084 | 0.033 | 0.084 | Vanilloid 4 agonist | |||
| 0.066 | 0.015 | 0.066 | Sodium/calcium exchanger inhibitor | |||
| 0.152 | 0.102 | 0.152 | Lipocortins synthesis antagonist | |||
| 0.137 | 0.087 | 0.137 | Neuropeptide Y1 antagonist | |||
| 0.073 | 0.023 | 0.073 | Kallikrein 7 inhibitor | 0.069 0.029 CID_154699508 | ||
| 0.073 | 0.024 | 0.073 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.193 | 0.144 | 0.193 | Transcription factor STAT3 inhibitor | |||
| 0.12 | 0.072 | 0.12 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.202 | 0.155 | 0.202 | Prostaglandin dehydrogenase inhibitor | |||
| 0.082 | 0.035 | 0.082 | Carbonic anhydrase VA inhibitor | |||
| 0.079 | 0.032 | 0.079 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.162 | 0.116 | 0.162 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.104 | 0.057 | 0.104 | Anabolic | |||
| 0.077 | 0.03 | 0.077 | 5 Hydroxytryptamine 2A agonist | |||
| 0.093 | 0.046 | 0.093 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.057 | 0.012 | 0.057 | Phosphoglycerate kinase inhibitor | |||
| 0.073 | 0.028 | 0.073 | Caspase 9 inhibitor | |||
| 0.164 | 0.119 | 0.164 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.057 | 0.013 | 0.057 | Dihydropteroate synthase inhibitor | |||
| 0.067 | 0.023 | 0.067 | MAP kinase kinase 9 inhibitor | |||
| 0.161 | 0.118 | 0.161 | Insulin sensitizer | |||
| 0.053 | 0.01 | 0.053 | Glutamate (mGluR8) agonist | 0.037 0.028 CID_154699508 | ||
| 0.179 | 0.136 | 0.179 | Calpain inhibitor | |||
| 0.074 | 0.031 | 0.074 | Adrenaline uptake inhibitor | |||
| 0.075 | 0.033 | 0.075 | Exportin-1 inhibitor | |||
| 0.134 | 0.092 | 0.134 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.059 | 0.018 | 0.059 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.086 | 0.044 | 0.086 | Alpha 2a adrenoreceptor antagonist | |||
| 0.079 | 0.038 | 0.079 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.082 | 0.041 | 0.082 | Histidine decarboxylase inhibitor | |||
| 0.09 | 0.049 | 0.09 | I kappa B kinase inhibitor | |||
| 0.07 | 0.029 | 0.07 | Phosphodiesterase 1C inhibitor | |||
| 0.064 | 0.024 | 0.064 | Dihydroorotate oxidase inhibitor | |||
| 0.066 | 0.026 | 0.066 | Alpha tubulin antagonist | |||
| 0.069 | 0.03 | 0.069 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.069 | 0.03 | 0.069 | Calcium channel P-type blocker | |||
| 0.067 | 0.028 | 0.067 | Botulinum neurotoxin type A inhibitor | |||
| 0.07 | 0.032 | 0.07 | I kappa B kinase 2 inhibitor | |||
| 0.165 | 0.128 | 0.165 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.081 | 0.044 | 0.081 | Glutamate dehydrogenase inhibitor | |||
| 0.055 | 0.018 | 0.055 | Histamine H2 receptor agonist | |||
| 0.052 | 0.015 | 0.052 | Glutamate (mGluR group II) antagonist | |||
| 0.121 | 0.085 | 0.121 | Toll-Like receptor 9 antagonist | |||
| 0.081 | 0.044 | 0.081 | MAP kinase kinase 7 inhibitor | |||
| 0.056 | 0.02 | 0.056 | Thymidylate synthase inhibitor | |||
| 0.045 | 0.01 | 0.045 | Uridine phosphorylase inhibitor | |||
| 0.045 | 0.01 | 0.045 | Liver X receptor beta antagonist | |||
| 0.111 | 0.076 | 0.111 | Beta amyloid protein antagonist | |||
| 0.098 | 0.063 | 0.098 | Glutamate (mGluR7) agonist | |||
| 0.085 | 0.051 | 0.085 | Estrogen-related receptor beta agonist | |||
| 0.208 | 0.175 | 0.208 | Vasodilator, coronary | |||
| 0.045 | 0.011 | 0.045 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.049 | 0.016 | 0.049 | AMPA 4 receptor antagonist | |||
| 0.069 | 0.036 | 0.069 | Beta 3 adrenoreceptor antagonist | |||
| 0.054 | 0.021 | 0.054 | Dihydroorotase inhibitor | |||
| 0.059 | 0.026 | 0.059 | Dopamine transporter inhibitor | |||
| 0.044 | 0.013 | 0.044 | Potassium channel small-conductance Ca-activated activator | |||
| 0.14 | 0.108 | 0.14 | LIM domain kinase 1 inhibitor | |||
| 0.099 | 0.067 | 0.099 | Alpha 2c adrenoreceptor antagonist | |||
| 0.036 | 0.005 | 0.036 | Alpha 2a adrenoreceptor agonist | |||
| 0.046 | 0.015 | 0.046 | Glutamate (mGluR3) antagonist | |||
| 0.082 | 0.051 | 0.082 | Glutamate receptor agonist | |||
| 0.049 | 0.018 | 0.049 | Dopamine D5 agonist | |||
| 0.046 | 0.016 | 0.046 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.052 | 0.022 | 0.052 | Glutamate (mGluR group III) agonist | |||
| 0.037 | 0.008 | 0.037 | Thymidine phosphorylase inhibitor | |||
| 0.05 | 0.021 | 0.05 | Kainate receptor antagonist | |||
| 0.047 | 0.018 | 0.047 | GABA uptake inhibitor | |||
| 0.11 | 0.081 | 0.11 | Transcription factor STAT6 inhibitor | |||
| 0.052 | 0.023 | 0.052 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.091 | 0.063 | 0.091 | ABCA1 expression enhancer | |||
| 0.033 | 0.005 | 0.033 | 5 Hydroxytryptamine 4 agonist | |||
| 0.052 | 0.024 | 0.052 | Carbonic anhydrase IV inhibitor | |||
| 0.072 | 0.044 | 0.072 | Purinergic P2X2 antagonist | |||
| 0.093 | 0.066 | 0.093 | Bile acid receptor antagonist | |||
| 0.086 | 0.059 | 0.086 | Alpha 2 adrenoreceptor antagonist | |||
| 0.045 | 0.019 | 0.045 | Diamine oxidase inhibitor | |||
| 0.058 | 0.032 | 0.058 | Epithelial sodium channel blocker | |||
| 0.039 | 0.012 | 0.039 | Glutamate (mGluR2) antagonist | |||
| 0.166 | 0.141 | 0.166 | ErbB-1 antagonist | |||
| 0.103 | 0.079 | 0.103 | Nav1.5 sodium channel blocker | |||
| 0.133 | 0.108 | 0.133 | Mcl-1 antagonist | |||
| 0.156 | 0.131 | 0.156 | Histone acetyltransferase inhibitor | |||
| 0.043 | 0.019 | 0.043 | Potassium channel Kv1.1 blocker | |||
| 0.098 | 0.074 | 0.098 | AMP-activated protein kinase stimulant | |||
| 0.105 | 0.082 | 0.105 | Microtubule formation inhibitor | |||
| 0.188 | 0.165 | 0.188 | 12-Lipoxygenase inhibitor | |||
| 0.034 | 0.01 | 0.034 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.07 | 0.047 | 0.07 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.03 | 0.008 | 0.03 | Complement factor 1s inhibitor | |||
| 0.07 | 0.048 | 0.07 | Phosphofructokinase-1 inhibitor | |||
| 0.046 | 0.024 | 0.046 | Nerve growth factor antagonist | |||
| 0.054 | 0.033 | 0.054 | Aconitate hydratase inhibitor | |||
| 0.183 | 0.162 | 0.183 | Transcription factor STAT inhibitor | |||
| 0.032 | 0.011 | 0.032 | NMDA receptor glycine site antagonist | |||
| 0.092 | 0.071 | 0.092 | Aminopeptidase B inhibitor | |||
| 0.06 | 0.04 | 0.06 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.044 | 0.025 | 0.044 | Liver X receptor alpha agonist | |||
| 0.09 | 0.071 | 0.09 | MAP kinase 9 inhibitor | |||
| 0.056 | 0.037 | 0.056 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.045 | 0.027 | 0.045 | Histamine H1 receptor agonist | |||
| 0.037 | 0.018 | 0.037 | Liver X receptor beta agonist | |||
| 0.023 | 0.005 | 0.023 | Thyroid hormone alpha agonist | |||
| 0.029 | 0.012 | 0.029 | Complement factor 1r inhibitor | |||
| 0.027 | 0.01 | 0.027 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.055 | 0.038 | 0.055 | Sphingosine kinase 2 inhibitor | |||
| 0.029 | 0.012 | 0.029 | Sodium/glucose cotransporter inhibitor | |||
| 0.021 | 0.004 | 0.021 | CC chemokine 10 receptor antagonist | 0.015 0.013 CID_154699508 | ||
| 0.03 | 0.013 | 0.03 | Thyroid hormone agonist | |||
| 0.051 | 0.034 | 0.051 | Potassium channel (Inward rectifier) activator | |||
| 0.055 | 0.038 | 0.055 | CC chemokine 2 receptor antagonist | |||
| 0.036 | 0.02 | 0.036 | Glutamate (mGluR4) agonist | |||
| 0.032 | 0.015 | 0.032 | MAP3K8 inhibitor | |||
| 0.063 | 0.047 | 0.063 | Dopamine D1 antagonist | |||
| 0.032 | 0.016 | 0.032 | Liver X receptor alpha antagonist | |||
| 0.049 | 0.033 | 0.049 | Histamine H4 receptor antagonist | |||
| 0.023 | 0.008 | 0.023 | Alpha 2c adrenoreceptor agonist | |||
| 0.048 | 0.033 | 0.048 | Glycine transporter inhibitor | |||
| 0.048 | 0.033 | 0.048 | Potassium channel (ATP-sensitive) activator | |||
| 0.061 | 0.046 | 0.061 | Beta 2 adrenoreceptor agonist | |||
| 0.196 | 0.181 | 0.196 | Vasodilator, peripheral | |||
| 0.07 | 0.055 | 0.07 | Glycine receptor agonist | |||
| 0.058 | 0.044 | 0.058 | Ryanodine receptor antagonist | |||
| 0.069 | 0.055 | 0.069 | Phospholipase D inhibitor | |||
| 0.084 | 0.07 | 0.084 | Phosphodiesterase I inhibitor | |||
| 0.03 | 0.016 | 0.03 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.055 | 0.042 | 0.055 | Alpha 1 adrenoreceptor agonist | |||
| 0.089 | 0.076 | 0.089 | Carbonic anhydrase III inhibitor | |||
| 0.096 | 0.083 | 0.096 | 5 Hydroxytryptamine antagonist | |||
| 0.021 | 0.009 | 0.021 | Alpha 2b adrenoreceptor agonist | |||
| 0.055 | 0.043 | 0.055 | Pregnane X receptor antagonist | |||
| 0.039 | 0.027 | 0.039 | Urate transporter 1 inhibitor | |||
| 0.055 | 0.043 | 0.055 | Adenosine A1 receptor antagonist | |||
| 0.053 | 0.042 | 0.053 | Alcohol oxidase inhibitor | |||
| 0.107 | 0.096 | 0.107 | Lck kinase inhibitor | |||
| 0.023 | 0.012 | 0.023 | Imidazoline I1 receptor antagonist | |||
| 0.053 | 0.043 | 0.053 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.061 | 0.051 | 0.061 | Transcription factor RelA inhibitor | |||
| 0.134 | 0.124 | 0.134 | DNA methyltransferase I inhibitor | |||
| 0.114 | 0.104 | 0.114 | Vanilloid 1 agonist | |||
| 0.034 | 0.025 | 0.034 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.139 | 0.131 | 0.139 | Neurotensin receptor agonist | |||
| 0.057 | 0.049 | 0.057 | Bcl-xL inhibitor | |||
| 0.086 | 0.077 | 0.086 | Vascular endothelial growth factor 1 antagonist | |||
| 0.028 | 0.02 | 0.028 | Purinergic P2Y15 antagonist | |||
| 0.026 | 0.019 | 0.026 | Nicotinic acid receptor 2 antagonist | |||
| 0.052 | 0.045 | 0.052 | Argininosuccinate synthase inhibitor | |||
| 0.019 | 0.012 | 0.019 | Cyclin T1 inhibitor | |||
| 0.081 | 0.074 | 0.081 | Bromodomain-containing protein 2 inhibitor | |||
| 0.057 | 0.05 | 0.057 | Phosphodiesterase 1A inhibitor | |||
| 0.076 | 0.07 | 0.076 | Androgen antagonist | |||
| 0.035 | 0.028 | 0.035 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.049 | 0.043 | 0.049 | Carbonic anhydrase IX inhibitor | |||
| 0.047 | 0.041 | 0.047 | Beta 2 adrenoreceptor antagonist | |||
| 0.062 | 0.057 | 0.062 | Potassium channel (ATP-sensitive) blocker | |||
| 0.095 | 0.09 | 0.095 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.012 | 0.007 | 0.012 | Purine nucleoside phosphorylase inhibitor | |||
| 0.041 | 0.036 | 0.041 | Phosphorylase inhibitor | |||
| 0.059 | 0.055 | 0.059 | Aryl hydrocarbon receptor antagonist | |||
| 0.114 | 0.109 | 0.114 | Cell wall synthesis inhibitor | |||
| 0.06 | 0.055 | 0.06 | Interferon inducer | |||
| 0.069 | 0.065 | 0.069 | CC chemokine receptor antagonist | |||
| 0.017 | 0.013 | 0.017 | CC chemokine 9 receptor antagonist | |||
| 0.085 | 0.081 | 0.085 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.071 | 0.068 | 0.071 | Interferon agonist | |||
| 0.108 | 0.104 | 0.108 | Alkaline phosphatase inhibitor | |||
| 0.043 | 0.04 | 0.043 | Beta adrenoreceptor agonist | |||
| 0.017 | 0.013 | 0.017 | Nicotinic acid receptor 1 antagonist | |||
| 0.029 | 0.026 | 0.029 | ATP citrate lysase inhibitor | |||
| 0.048 | 0.045 | 0.048 | Carbonic anhydrase I inhibitor | |||
| 0.063 | 0.06 | 0.063 | HIV-1 integrase inhibitor | |||
| 0.129 | 0.125 | 0.129 | Antipruritic | |||
| 0.038 | 0.035 | 0.038 | Oxytocin agonist | |||
| 0.043 | 0.04 | 0.043 | AMPA receptor antagonist | |||
| 0.024 | 0.022 | 0.024 | CXC chemokine 2 receptor antagonist | |||
| 0.103 | 0.1 | 0.103 | Acetylcholinesterase inhibitor | |||
| 0.007 | 0.005 | 0.007 | DNA topoisomerase III inhibitor | |||
| 0.04 | 0.038 | 0.04 | Geranyltranstransferase inhibitor | |||
| 0.028 | 0.026 | 0.028 | Liver X receptor antagonist | |||
| 0.038 | 0.037 | 0.038 | Kainate receptor agonist | |||
| 0.024 | 0.023 | 0.024 | Lysine carboxypeptidase inhibitor | |||
| 0.064 | 0.063 | 0.064 | Glutamate decarboxylase inhibitor | |||
| 0.03 | 0.029 | 0.03 | Fumarate hydratase inhibitor | |||
| 0.065 | 0.17 | 0.976 | Epidermal growth factor receptor kinase inhibitor | 0.976 0.003 CID_154699508 | CID_154699508 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |